Antidepressant Use in Pregnancy Raises Miscarriage Risk

Taking antidepressants during pregnancy can increase the risk of miscarriage in mums-to-be, according to a new study. Antidepressants are widely used in pregnancy. Discontinuing treatment can result in a depressive relapse which can put mother and baby at risk.

The new study sought to determine the association between antidepressant use in pregnancy, including classes, types and doses, and the risk of miscarriage.

To come up with the conclusion, boffins from the University of Montreal and the CHU Ste-Justine looked at data on 5124 women in Quebec from a large population-based cohort of pregnant women who had clinically verified miscarriages up to 20 weeks of gestation and a large sample of women from the same Registry who did not have a miscarriage. Of those who miscarried, 284 had taken antidepressants during pregnancy.

Selective serotonin reuptake inhibitors (SSRIs), especially paroxetine and also venlafaxine were associated with increased risk of miscarriage as were higher daily doses of either antidepressant. As well, a combination of different antidepressants doubled the risk of miscarriages.

"These results, which suggest an overall class effect of selective serotonin reuptake inhibitors, are highly robust given the large number of users studied," writes senior author Dr. Anick Bérard, from the University of Montreal and the Director of the Research Unit on Medications and Pregnancy at CHU Ste-Justine.

The researchers urge that physicians who have patients of child-bearing age taking antidepressants or have pregnant patients who require antidepressant therapy early in pregnancy discuss the risks and benefits with them.

Advertisement

Source-ANI
SRM